Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Psoriasis/immunology"'
Publikováno v:
Emmanuel, T, Mistegård, J, Bregnhøj, A, Johansen, C & Iversen, L 2021, ' Tissue-Resident Memory T Cells in Skin Diseases : A Systematic Review ', International Journal of Molecular Sciences, vol. 22, no. 16 . https://doi.org/10.3390/ijms22169004
Emmanuel, T, Mistegård, J, Bregnhøj, A, Johansen, C & Iversen, L 2021, ' Tissue-resident memory t cells in skin diseases : A systematic review ', International Journal of Molecular Sciences, vol. 22, no. 16, 9004 . https://doi.org/10.3390/ijms22169004
International Journal of Molecular Sciences, Vol 22, Iss 9004, p 9004 (2021)
International Journal of Molecular Sciences
Emmanuel, T, Mistegård, J, Bregnhøj, A, Johansen, C & Iversen, L 2021, ' Tissue-resident memory t cells in skin diseases : A systematic review ', International Journal of Molecular Sciences, vol. 22, no. 16, 9004 . https://doi.org/10.3390/ijms22169004
International Journal of Molecular Sciences, Vol 22, Iss 9004, p 9004 (2021)
International Journal of Molecular Sciences
In health, the non-recirculating nature and long-term persistence of tissue-resident memory T cells (TRMs) in tissues protects against invading pathogens. In disease, pathogenic TRMs contribute to the recurring traits of many skin diseases. We aimed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73c03022c2b85aa284021f6cea28c526
https://pure.au.dk/portal/da/publications/tissueresident-memory-t-cells-in-skin-diseases(c373c8f6-96ef-4ca6-81ac-d18f7b623ec8).html
https://pure.au.dk/portal/da/publications/tissueresident-memory-t-cells-in-skin-diseases(c373c8f6-96ef-4ca6-81ac-d18f7b623ec8).html
Autor:
Yashaswi Shrestha, Alison A. Humbles, Jan Koster, Menno A. de Rie, Jochem H. Bernink, Xavier Romero Ros, Richard Volckmann, Lisette Krabbendam, Christine Guntermann, Ivan Ramirez, Yoichiro Ohne, Jincheng Wu, Sophie van Tol, Marcel B. M. Teunissen, Hergen Spits, Jingya Wang
Publikováno v:
Nature immunology, 20(8), 992-1003. Nature Publishing Group
Here we identify a group 2 innate lymphoid cell (ILC2) subpopulation that can convert into interleukin-17 (IL-17)-producing NKp44− ILC3-like cells. c-Kit and CCR6 define this ILC2 subpopulation that exhibits ILC3 features, including RORγt, enablin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0df360fe580eeb51846bc8f629059ebb
https://doi.org/10.1038/s41590-019-0423-0
https://doi.org/10.1038/s41590-019-0423-0
Autor:
Alexander A. Navarini, Curdin Conrad, Alessio Mylonas, Anne-Karine Lapointe, Jeremy Di Domizio, Olivier Demaria, Michel Gilliet, Cyrine Belkhodja, Lars E. French, Maxime Vernez
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-11 (2018)
Nature Communications
Nature communications, vol. 9, no. 1, pp. 25
Nature Communications
Nature communications, vol. 9, no. 1, pp. 25
Although anti-tumor necrosis factor (TNF) agents are highly effective in the treatment of psoriasis, 2–5% of treated patients develop psoriasis-like skin lesions called paradoxical psoriasis. The pathogenesis of this side effect and its distinction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbbc7decb248c10970a313c075620f0f
https://doaj.org/article/180fc992d72e4fcbbf1d606055e86015
https://doaj.org/article/180fc992d72e4fcbbf1d606055e86015
Autor:
Mylonas, A., Conrad, C.
Publikováno v:
Frontiers in immunology, vol. 9, pp. 2746
Chronic plaque psoriasis is a common debilitating skin disease. The identification of the pathogenic role of the TNF/IL-23/T H 17 pathway has enabled the development of targeted therapies used in the clinic today. Particularly, TNF inhibitors have be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1900::1c42725342dd78d0a9c3d838fe45d153
https://serval.unil.ch/notice/serval:BIB_57A9835FCAA8
https://serval.unil.ch/notice/serval:BIB_57A9835FCAA8
Autor:
Alessio Mylonas, Federica Villanova, Frank O. Nestle, Isabella Tosi, Curdin Conrad, Alexander A. Navarini, Paola Di Meglio
Publikováno v:
The Journal of allergy and clinical immunology, vol. 138, no. 1, pp. 274-276.e6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11f944293525776cf93f45ecdbc7c4e8
https://serval.unil.ch/notice/serval:BIB_14A789D6773B
https://serval.unil.ch/notice/serval:BIB_14A789D6773B
Autor:
Lukas Flatz, Pascale Zwicky, Alexander A. Navarini, Phil F. Cheng, Burkhard Becher, Reinhard Dummer, Tom Hartwig, Nikhil Yawalkar, Curdin Conrad, Bettina Schreiner, Christoph Schlapbach
Publikováno v:
Cell Reports, Vol 25, Iss 13, Pp 3564-3572.e4 (2018)
Cell reports, vol. 25, no. 13, pp. 3564-3572.e4
Hartwig, Tom; Zwicky, Pascale; Schreiner, Bettina; Yawalkar, Nikhil; Cheng, Phil; Navarini, Alexander; Dummer, Reinhard; Flatz, Lukas; Conrad, Curdin; Schlapbach, Christoph; Becher, Burkhard (2018). Regulatory T Cells Restrain Pathogenic T Helper Cells during Skin Inflammation. Cell reports, 25(13), 3564-3572.e4. Cell Press 10.1016/j.celrep.2018.12.012
Cell reports, vol. 25, no. 13, pp. 3564-3572.e4
Hartwig, Tom; Zwicky, Pascale; Schreiner, Bettina; Yawalkar, Nikhil; Cheng, Phil; Navarini, Alexander; Dummer, Reinhard; Flatz, Lukas; Conrad, Curdin; Schlapbach, Christoph; Becher, Burkhard (2018). Regulatory T Cells Restrain Pathogenic T Helper Cells during Skin Inflammation. Cell reports, 25(13), 3564-3572.e4. Cell Press 10.1016/j.celrep.2018.12.012
Summary: Psoriasis is a chronic relapsing, remitting interleukin (IL)-23/IL-17-driven skin disease mediated by the interplay of T cells and polymorphonuclear granulocytes. Although preclinical studies have provided insights into the mechanisms of dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f131119d7f83da2ba133932aa15121a7
https://doi.org/10.1016/j.celrep.2018.12.012
https://doi.org/10.1016/j.celrep.2018.12.012
Autor:
Stephanie Zwicker, D. Bureik, Aleksandra Batycka-Baran, Thomas Ruzicka, Simon Rothenfusser, Andreas Schmidt, Ronald Wolf, Michel Gilliet, Eva Hattinger, Peter-Arne Gerber
Publikováno v:
PLoS ONE, Vol 12, Iss 4, p e0175153 (2017)
PloS one, vol. 12, no. 4, pp. e0175153
PLoS ONE
PloS one, vol. 12, no. 4, pp. e0175153
PLoS ONE
IL-1β is a potent player in cutaneous inflammation and central for the development of a Th17 micro-milieu in autoinflammatory diseases including psoriasis. Its production is controlled at the transcriptional level and by subsequent posttranslational
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0206ce2320093f408cfb6eb3ea3f67da
https://doi.org/10.1371/journal.pone.0175153
https://doi.org/10.1371/journal.pone.0175153
Publikováno v:
Acta Dermato-Venereologica. 87:261-263
still positive). The positive staining had the same pattern (chain-like) and intensity as before. Two sera previously giving weak IIF staining were now negative. There had been only mild changes in the clinical conditions in the majority of these pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd65af8924ba4b8ff7f44f22422c2669
https://doi.org/10.2340/00015555-0217
https://doi.org/10.2340/00015555-0217
Publikováno v:
Acta dermato-venereologica. 77(2):105-109
Heparan sulfate proteoglycans (HSPGs) are components of the basement membrane (BM) of various tissues. They consist of a core protein and negatively charged glycosaminoglycan side chains: the heparan sulfate (HS) moieties. In psoriasis, uninvolved sk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dris___00893::b0a87c728a0558c63bacc2bf74396637
https://hdl.handle.net/11370/453b6aea-64eb-4489-bd64-657f5b24b5bf
https://hdl.handle.net/11370/453b6aea-64eb-4489-bd64-657f5b24b5bf
Publikováno v:
Liječnički vjesnik
Volume 132
Issue 11-12
Volume 132
Issue 11-12
Psorijaza je kronično-recidivirajuća upalna bolest kože obilježena poremećajem diferencijacije i proliferacije keratinocita te upalnim infiltratom, mahom T-limfocita u dermisu i epidermisu. Dosadašnje spoznaje upućuju da je psorijaza genski po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::ebb237dcff4da69d31c501f64324a2bb
https://hrcak.srce.hr/file/323293
https://hrcak.srce.hr/file/323293